# A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants

> **NCT06679413** · PHASE1 · COMPLETED · sponsor: **UCB BIOSCIENCES, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Healthy Study Participants

## Interventions

- **DRUG:** midazolam
- **DRUG:** metformin
- **DRUG:** bupropion
- **DRUG:** fenfluramine HCl

## Key facts

- **NCT ID:** NCT06679413
- **Lead sponsor:** UCB BIOSCIENCES, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-04
- **Primary completion:** 2025-06-12
- **Final completion:** 2025-06-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06679413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06679413, "A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06679413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*